| 中文名 | 21-羟基孕甾-1,4,9(11),16-四烯-3,20-二酮-21-醋酸酯 |
|---|---|
| 英文名 | [2-[(8S,10S,13S,14S)-10,13-dimethyl-3-oxo-6,7,8,12,14,15-hexahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate |
| 中文别名 |
泼尼松杂质12
四烯物 莫米松相关化合物4 醋酸四烯物 布地奈德杂质对照品6 21-羟基孕甾-1,4,9,16-四烯-3,20-二酮-21- 醋酸酯(3TR) 醋酸四烯物(3TR) 醋酸四烯物(3TR) / 21-羟基孕甾-1,4,9,16-四烯-3,20-二酮-21-醋酸酯 2-((8S,10S,13S,14S)-10,13-二甲基-3-氧代-6,7,8,10,12,13,14,15-八氢-3H-环戊二烯并[A]菲-17-基)-2-氧代乙基 乙酸酯 21-乙酰氧基孕甾-1,4,9(11),16-四烯-3,20-酮 21-羟基孕甾-1,4,9,16-四烯-3,20-二酮-21-醋酸酯 21-乙酰氧基孕甾-1,4,9,16-四烯-3,20-二酮 16-四烯-3,20-二酮-21-醋酸酯 21-乙酰氧基孕甾-1,4,9,16-四烯-3,20-酮 |
| 英文别名 |
Tetraene acetate[3TR]
21-(Acetyloxy)pregna-1,4,9(11),16-tetraene-3,20-dione 21-acetoxy-pregna-1,4,9(11),16-tetraene-3,20-dione Pregna-1,4,9,16-tetraen Pregna-1,4,9,16-tetraen-21-ol-3,20-dione 21-acetate 21-Acetoxypregna-1,4,9,16-tetrene-3,20-dione 3,20-Dioxopregna-1,4,9,16-tetrene-21-ol acetate EINECS 253-497-3 16-tetraene-3,20-dione 21-acetate 3,20-Dioxopregna-1,4,9(11),16-tetraen-21-yl acetate 21-Acetoxypregna-1,4,9,16-tetraene-3,20-dione 21-hydroxy-pregna-1,4,9(11),16-tetraene-3,20-dione 21-acetate Prednisolone impurity 8/21-(Acetyloxy)-pregna-1,4,9,16-tetraene-3,20-dione 2-((8S,10S,13S,14S)-10,13-DiMethyl-3-oxo-6,7,8,10,12,13,14,15-octahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate Prednisone Impurity 12 3,20-dioxopregna-1,4,9,16-tetraen-21-yl acetate 21-hydroxyprogesterone-1,4,9 , 16-tetraene-3,20-dione-21-acetate 21-hydroxypregna-1,4,9(11) 16-tetraen-21-yl Tetraen Acetate(3TR) 21-Hydroxy-1,4,9-tetraene 21-acetate 21-(Acetyloxy)-pregna-1,4,9,16-tetraene-3,20-dione 1,4,9,16-Prenatetraene-21-ol-3,20-dione-17-acetate Mometasone Related Compound 4 21-Acetoxy-pregna-1,4,9(11),16-tetraen-3,20-dion Tetraen-acetic acid complex Pregna-1,4,9,16-tetraene-3,20-dione,21-(acetyloxy) 3,20-Dioxopregna-1,4,9,16-tetraen-21-yl acetate ISO 9001:2015 REACH 1,4,9,16-PREGNATETRAENE-21-OL-3,20-DIONE-21-ACETATE(3TR) CAS#37-5 21-hydroxypregna-1,4,9,16-tetraene-3,20-dione 21-acetate Acetate tetraene Matter 2-((8S,10S,13S,14S)-10,13-dimethyl-3-oxo-6,7,8,10,12,13,14,15-octahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate |
| 描述 | 21-Acetoxypregna-1,4,9(11),16-tetraene-3,20-dione 是 delta 9,11 类固醇类合成的中间体 (intermediate),如 Vamorolone (HY-109017)。delta 9,11 steroids 是糖皮质激素的修饰后的产物,具有抗炎 (anti-inflammatory) 特性。delta 9,11 类固醇类可以用作保护细胞损伤(脂质过氧化)和抑制新生血管的试剂。 |
|---|---|
| 相关类别 | |
| 体外研究 | Δ9,11衍生物的设计和开发能够稳定地结合到细胞膜中并抑制脂质过氧化,而无糖皮质激素或盐皮质激素活性,从而避免与传统皮质类固醇相关的副作用[1]。VBP15作为一种先导化合物,由于有效的NF-κB抑制和GR易位类似于强的松和地塞米松,缺乏反式激活特性和良好的生物利用度[1]。 |
| 参考文献 |
| 密度 | 1.2±0.1 g/cm3 |
|---|---|
| 沸点 | 534.6±50.0 °C at 760 mmHg |
| 分子式 | C23H26O4 |
| 分子量 | 366.450 |
| 闪点 | 233.0±30.2 °C |
| 精确质量 | 366.183105 |
| PSA | 60.44000 |
| LogP | 3.48 |
| 蒸汽压 | 0.0±1.4 mmHg at 25°C |
| 折射率 | 1.585 |
| 储存条件 | 室温,干燥 |
|
~%
37413-91-5 |
| 文献:Schaub et al. Journal of the American Chemical Society, 1959 , vol. 81, p. 4962,4966 |
|
~%
37413-91-5 |
| 文献:Hulcoop, David G.; Shapland, Peter D.P. Steroids, 2013 , vol. 78, # 12-13 p. 1281 - 1287 |
|
~%
37413-91-5 |
| 文献:Am.Cyanamid Co. Patent: US2864834 , 1957 ; |
| 上游产品 3 | |
|---|---|
| 下游产品 1 | |